Payment And Incentives

Health care is unusual among markets in that the person who receives a service rarely pays for it directly, and the person who orders it is often not the person who bears its cost.

9 frameworks, from 1963 to today · Health Services Research · Medicine & Health

still a working view ended · each leads to its entry below

Overview

Health care is unusual among markets in that the person who receives a service rarely pays for it directly, and the person who orders it is often not the person who bears its cost1. Payment and incentives is the subfield of health services research that studies this triangle: how money flows to doctors, hospitals, and other providers, and how the shape of that flow changes what they do2. Its central insight is that payment is not a neutral bookkeeping arrangement but a set of instructions. Change how a provider is paid and you change which patients they accept, which services they offer, how hard they work, and sometimes whether they tell the truth. The field's history is a long argument about how powerful those instructions are, how cleverly providers respond to them, and whether any payment design can align what is good for the provider with what is good for the patient and the public purse.

The Insurance Problem and the Birth of Moral Hazard

Modern payment research begins with insurance. In the 1960s, economists applied the new tools of information economics to health coverage and identified a structural problem: once a person is insured, the price they face at the point of care falls toward zero, so they consume more care than they would if they paid the full cost. This is moral hazard — not dishonesty, but the ordinary response of any insured person to a lower price3. The term had been used in insurance since the nineteenth century; health economists gave it a precise meaning and a policy edge3.

The decisive empirical test came with the RAND Health Insurance Experiment, a randomized trial run in the United States between the mid-1970s and early 1980s. Families were assigned to insurance plans with different levels of cost-sharing, from free care to a large deductible. The result was unambiguous: people with free care used substantially more services than those with cost-sharing, and the extra care produced little measurable improvement in health for the average person. The experiment established that demand responds to price and that insurance design is itself an incentive instrument. It also sharpened a question that has driven the field ever since: if patients respond to price, how do providers respond to payment?

Supplier-Induced Demand and the Physician as Agent

The physician occupies a strange position: the patient trusts the doctor to recommend care, but the doctor also sells that care. In the 1970s, health economists began modeling this as an agency relationship — the physician acts as the patient's agent, but with their own income at stake. The concept of supplier-induced demand described the possibility that physicians, facing a target income or a fall in their patient base, could shift the care they recommend in ways that serve their income rather than the patient's need.

The evidence was contested from the start. Studies of regions with different physician-to-population ratios found that areas with more surgeons performed more surgery, a pattern consistent with induced demand but also explainable by patient preferences or illness patterns. Researchers developed indirect tests — watching how physicians' practice changed when fees changed, or when new physicians entered a market — and the debate over how much induction actually occurs has never fully closed. What the debate achieved was durable: it made the physician's dual role a permanent feature of payment design, and it gave the field its central vocabulary of agency and conflict of interest. Any payment scheme must reckon with the fact that the person deciding what care is needed may benefit from deciding that more is needed.

Capitation, Managed Care, and the Shift of Risk

If fee-for-service pays for volume, its opposite is capitation: a fixed payment per patient per period, regardless of how much care that patient uses4. Under capitation the provider bears the financial risk of illness, so the incentive flips from doing more to doing less. The idea is old — prepaid group practices existed in the United States in the early twentieth century — but it became a mass phenomenon with the managed care movement of the 1980s and 1990s, when health maintenance organizations (HMOs) enrolled millions of Americans under capitated and gatekept arrangements.

Managed care was a natural experiment in incentive design, and it taught the field two lessons. First, capitation works: it restrained spending and reduced hospitalization. Second, it can work too well. Concerns about underprovision — skimping on necessary care, selecting healthier patients, and restricting access — produced a public backlash in the late 1990s and a retreat toward softer forms of risk-sharing. The episode established the field's recurring trade-off: payment that rewards restraint creates incentives to withhold, just as payment that rewards volume creates incentives to overprovide. The design problem is to find a payment that rewards the right care rather than more or less care.

Pay-for-Performance and the Quality Turn

By the 2000s, attention shifted from volume and cost to quality. Pay-for-performance (P4P) pays providers a bonus for meeting measured targets — vaccination rates, blood-pressure control, timely screening5. The logic was appealing: if payment can shape behavior, pay for the behavior you want. Programs spread through the United States, the United Kingdom, and elsewhere; the UK's Quality and Outcomes Framework, introduced in 2004, paid general practitioners substantially for achieving clinical indicators and produced measurable gains in recorded performance.

But the evidence accumulated cautiously. Reviews of P4P trials found modest average effects, with gains concentrated in areas where measurement was easy and often accompanied by unintended responses — attention shifting toward measured targets and away from unmeasured aspects of care. The field learned that what gets measured gets managed, and that incentive schemes can distort as well as direct. P4P also raised a deeper question: whether financial incentives crowd out the intrinsic motivation that draws people into medicine in the first place.

Behavioral Economics and the Design of Incentives

That question opened the door to behavioral economics, which brought psychology into payment design6. The older model assumed a rational provider weighing marginal income against marginal effort. Behavioral research showed that people respond to how incentives are framed, to loss versus gain, to social comparison, and to defaults. A bonus framed as a potential loss may motivate more than the same sum framed as a gain; public reporting of performance can move behavior through reputation as much as money. The field began to treat incentive design as a craft informed by how people actually decide, not just by how much they are paid. This strand also fed into audit and feedback and other implementation strategies, where the incentive is information and comparison rather than cash.

Episode-Based and Total-Cost Contracting

The most ambitious turn came with attempts to pay for whole episodes and whole populations rather than individual services. Bundled payment sets a single price for all the care surrounding a procedure or condition — a hip replacement, a cardiac bypass — so that providers keep savings if they coordinate efficiently and absorb losses if they do not7. The idea was piloted in the United States in the 1980s and revived on a large scale in the 2010s7. Results were mixed: some bundles reduced spending modestly, others showed little effect, and the design demanded careful definition of what the episode includes.

Accountable care organizations (ACOs), launched in the United States from 2012 under the Affordable Care Act, went further: a group of providers takes responsibility for the total cost and quality of a defined population, sharing in savings if it meets quality standards. The model descends directly from capitation and managed care but softens the risk with shared-savings arrangements. Evaluations found modest savings in some programs and little in others, and the field continues to debate whether the savings come from genuine care improvement or from favorable patient selection. The ACO experiment is the clearest contemporary expression of the field's oldest ambition: to pay for health rather than for activity.

Results-Based Financing in Global Health

Outside high-income systems, the same logic took a different form. Results-based financing (RBF) — paying for verified results rather than inputs — spread through low- and middle-income countries from the 2000s, supported by the World Bank and others. Programs paid health facilities for the services they actually delivered, or paid for outcomes such as institutional deliveries or vaccination coverage. The approach drew on the same incentive reasoning as P4P but operated in settings where the prior problem was often too little care rather than too much. Evidence was mixed and context-dependent: RBF could raise the volume of priority services, but effects on quality and on health outcomes were uneven, and the schemes raised questions about measurement, gaming, and whether paying for results strengthened or distorted fragile health systems. The global strand made the field's questions genuinely worldwide: the same tension between rewarding activity and rewarding outcomes appears whether the payer is a national insurer or an international donor.

The Present: A Field of Trade-offs

Today the subfield is defined less by a single winning design than by a mature understanding of trade-offs. Fee-for-service rewards volume; capitation rewards restraint; P4P rewards measured quality; bundles and ACOs reward coordination and total-cost discipline; behavioral design shapes how any of these are experienced84579. The dominant research approach combines economic theory with quasi-experimental evaluation — difference-in-differences, regression discontinuity, randomized programs — to ask what each design actually does in practice. The open questions are the ones the history kept producing: how to measure quality without distorting it, how to reward good care without rewarding patient selection, how much risk providers can bear without withdrawing from care for the sickest, and whether financial incentives strengthen or erode the professional commitment that payment is meant to support. The field's history is the record of learning that payment is a powerful lever, that providers respond to it in predictable and unpredictable ways, and that designing it well remains an unsolved craft.

References

  1. Health economics, Wikipedia
  2. Health services research, Wikipedia
  3. Moral hazard (introduction, History), Wikipedia
  4. Capitation (healthcare), Wikipedia
  5. Pay for performance (healthcare), Wikipedia
  6. Behavioral economics, Wikipedia
  7. Bundled payment (introduction, History), Wikipedia
  8. Fee-for-service, Wikipedia
  9. Accountable care organization, Wikipedia

The frameworks of Payment And Incentives

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1963-Present

    Moral Hazard and Demand Response

    How does insurance change how much care people use?

    Fly to its tower in Nousfarer

  2. 1970-Present

    Supplier-induced demand

    Do doctors provide more care because they profit from it?

    Fly to its tower in Nousfarer

  3. 1973-Present

    Capitation

    What happens when providers are paid a fixed amount per patient?

    Fly to its tower in Nousfarer

  4. 1985-Present

    Bundled payment

    Can a single price for a whole episode improve care?

    Fly to its tower in Nousfarer

  5. 1985-Present

    Quasi-Experimental Program Evaluation

    How can we tell whether a program actually caused a change?

    Fly to its tower in Nousfarer

  6. 1990-Present

    Incentive-centered design

    How do people actually respond to incentives and frames?

    Fly to its tower in Nousfarer

  7. 2000-Present

    Output-based aid

    Does paying for results improve health services in poor countries?

    Fly to its tower in Nousfarer

  8. 2000-Present

    Pay-for-Performance

    Does paying for measured quality improve patient care?

    Fly to its tower in Nousfarer

  9. 2012-Present

    Accountable care organization

    Can providers be paid for keeping a population healthy?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Moral Hazard and Demand ResponseSupplier-induced demandCapitationBundled paymentQuasi-Experimental Program EvaluationIncentive-centered designOutput-based aidPay-for-PerformanceAccountable care organization

Beyond the field

Where Payment And Incentives's ideas came from in other fields, and what they led to there: the strongest 12 of 30 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Payment And Incentives is a planet in Nousfarer

Its city has a tower for each of these 9 frameworks. Land, walk in, and climb one concept at a time.

Land on Payment And Incentives

Related fields

Fields its ideas are linked to

More in Health Services Research

See where Payment And Incentives sits on the Map of Human Knowledge